Ngā hua rapu kaituhi

1

How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis mā Rubinstein, Samuel M., Stockerl-Goldstein, Keith

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury mā Crees, Zachary D., Stockerl-Goldstein, Keith

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis mā Zhang, Kathleen W., Stockerl-Goldstein, Keith E., Lenihan, Daniel J.

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments mā Martínez, José Carlos, Sica, R. Alejandro, Stockerl-Goldstein, Keith, Rubinstein, Samuel M.

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Retrospective comparison of allogeneic versus autologous transplantation for diffuse large B cell lymphoma with early relapse or primary induction failure mā Ghobadi, Armin, Nolley, Eric, Liu, Jingxia, McBride, Ali, Stockerl-Goldstein, Keith, Cashen, Amanda

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma mā Crees, Zachary D, Stockerl-Goldstein, Keith, Vainstein, Abi, Chen, Hemda, DiPersio, John F

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation mā Fiala, Mark A., Park, Soo, Slade, Michael, DiPersio, John F., Stockerl-Goldstein, Keith E.

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome mā Wu, Peggy A., Kim, Youn H., Lavori, Phillip W., Hoppe, Richard T., Stockerl-Goldstein, Keith E.

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Secondary Acute Lymphoblastic Leukemia, a retrospective analysis from Washington University and meta-analysis of published data. mā Ferraro, Francesca, Gao, Feng, Stockerl-Goldstein, Keith, Westervelt, Peter, DiPersio, John F., Ghobadi, Armin

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma mā Fiala, Mark A., Finney, Joseph D., Liu, Jingxia, Stockerl-Goldstein, Keith E., Tomasson, Michael H., Vij, Ravi, Wildes, Tanya M.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Geriatric assessment in older adults with multiple myeloma mā Wildes, Tanya M., Tuchman, Sascha A., Klepin, Heidi D., Mikhael, Joseph, Trinkaus, Kathryn, Stockerl-Goldstein, Keith, Vij, Ravi, Colditz, Graham

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

High dose therapy and autologous stem cell transplant in older adults with multiple myeloma mā Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

$An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment$

An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment mā Dimopoulos, Meletios A., Mikhael, Joseph, Terpos, Evangelos, Leleu, Xavier, Moreau, Philippe, Bladé, Joan, Kim, Jin Seok, Stockerl-Goldstein, Keith, Richardson, Paul G.

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

$Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML$

Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML mā Ramsingh, Giridharan, Westervelt, Peter, McBride, Ali, Stockerl-Goldstein, Keith, Vij, Ravi, Uy, Geoffrey, Cashen, Amanda, DiPersio, John F., Abboud, Camille N.

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma mā Ghobadi, Armin, Fiala, Mark A, Rettig, Michael, Schroeder, Mark, Uy, Geoffrey L., Stockerl-Goldstein, Keith, Westervelt, Peter, Vij, Ravi, DiPersio, John F

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

The Effect of Donor Type on Outcomes in Adults with Acute Myeloid Leukemia after Reduced Intensity Hematopoietic Peripheral Blood Cell Transplant mā Rashid, Nahid, Slade, Michael, Abboud, Ramzi, Gao, Feng, DiPersio, John F., Westervelt, Peter, Uy, Geoffrey, Stockerl-Goldstein, Keith, Romee, Rizwan, Schroeder, Mark A.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor mā Fadini, Gian Paolo, Fiala, Mark, Cappellari, Roberta, Danna, Marianna, Park, Soo, Poncina, Nicol, Menegazzo, Lisa, Albiero, Mattia, DiPersio, John, Stockerl-Goldstein, Keith, Avogaro, Angelo

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Fresh or Cryopreserved CD34(+)-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function following Allogeneic Hematopoietic Cell Transp... mā Ghobadi, Armin, Fiala, Mark A., Ramsingh, Giridharan, Gao, Feng, Abboud, Camille N., Stockerl-Goldstein, Keith, Uy, Geoffrey L., Grossman, Brenda J., Westervelt, Peter, DiPersio, John F.

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study mā Jagannath, Sundar, Laubach, Jacob, Wong, Ellice, Stockerl‐Goldstein, Keith, Rosenbaum, Cara, Dhodapkar, Madhav, Jou, Ying‐Ming, Lynch, Mark, Robbins, Michael, Shelat, Suresh, Anderson, Kenneth C., Richardson, Paul G.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

$A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma$

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma mā Schroeder, Mark A., Fiala, Mark A., Huselton, Eric, Cardone, Michael H., Jaeger, Savina, Jean, Sae Rin, Shea, Kathryn, Ghobadi, Armin, Wildes, Tanya M., Stockerl-Goldstein, Keith E., Vij, Ravi

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Stockerl‐Goldstein, Keith

How to Screen for Monoclonal Gammopathy in Patients With a Suspected Amyloidosis mā Rubinstein, Samuel M., Stockerl-Goldstein, Keith

COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury mā Crees, Zachary D., Stockerl-Goldstein, Keith

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis mā Zhang, Kathleen W., Stockerl-Goldstein, Keith E., Lenihan, Daniel J.

COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments mā Martínez, José Carlos, Sica, R. Alejandro, Stockerl-Goldstein, Keith, Rubinstein, Samuel M.

Retrospective comparison of allogeneic versus autologous transplantation for diffuse large B cell lymphoma with early relapse or primary induction failure mā Ghobadi, Armin, Nolley, Eric, Liu, Jingxia, McBride, Ali, Stockerl-Goldstein, Keith, Cashen, Amanda

GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma mā Crees, Zachary D, Stockerl-Goldstein, Keith, Vainstein, Abi, Chen, Hemda, DiPersio, John F

Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation mā Fiala, Mark A., Park, Soo, Slade, Michael, DiPersio, John F., Stockerl-Goldstein, Keith E.

A Meta-analysis of Patients Receiving Allogeneic or Autologous Hematopoietic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome mā Wu, Peggy A., Kim, Youn H., Lavori, Phillip W., Hoppe, Richard T., Stockerl-Goldstein, Keith E.

Secondary Acute Lymphoblastic Leukemia, a retrospective analysis from Washington University and meta-analysis of published data. mā Ferraro, Francesca, Gao, Feng, Stockerl-Goldstein, Keith, Westervelt, Peter, DiPersio, John F., Ghobadi, Armin

Socioeconomic Status is Independently Associated with Overall Survival in Patients with Multiple Myeloma mā Fiala, Mark A., Finney, Joseph D., Liu, Jingxia, Stockerl-Goldstein, Keith E., Tomasson, Michael H., Vij, Ravi, Wildes, Tanya M.

Geriatric assessment in older adults with multiple myeloma mā Wildes, Tanya M., Tuchman, Sascha A., Klepin, Heidi D., Mikhael, Joseph, Trinkaus, Kathryn, Stockerl-Goldstein, Keith, Vij, Ravi, Colditz, Graham

High dose therapy and autologous stem cell transplant in older adults with multiple myeloma mā Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham

An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment mā Dimopoulos, Meletios A., Mikhael, Joseph, Terpos, Evangelos, Leleu, Xavier, Moreau, Philippe, Bladé, Joan, Kim, Jin Seok, Stockerl-Goldstein, Keith, Richardson, Paul G.

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor mā Fadini, Gian Paolo, Fiala, Mark, Cappellari, Roberta, Danna, Marianna, Park, Soo, Poncina, Nicol, Menegazzo, Lisa, Albiero, Mattia, DiPersio, John, Stockerl-Goldstein, Keith, Avogaro, Angelo

Ngā utauta rapu: